Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subphenotype- and Complication-guided Adjunctive Fosfomycin Therapy for Staphylococcus Aureus Bacteraemia: Pooled Analysis of Two Randomised Trials

NCT07155590 is registered in ClinicalTrials.gov with Hospital Universitari de Bellvitge as lead sponsor.

NCT NCT07155590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07155590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subphenotype- and Complication-guided Adjunctive Fosfomycin Therapy for Staphylococcus Aureus Bacteraemia: Pooled Analysis of Two Randomised Trials
Lead sponsor
Hospital Universitari de Bellvitge
Phase
Observational
Overall status
Active, not recruiting
Start date
July 21, 2025
Completion date
September 15, 2025
Enrollment
369 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

staphylococcal aureus infection, staphylococcus aureus bacteraemia